Increased difference between slow and forced vital capacity is associated with reduced exercise tolerance in COPD patients

BMC Pulmonary Medicine

Volumn 14, Issue 1, 2014, Pages

  Yuan, Wei ^a   He, Xin ^a   Xu, Qiu Fen ^a   Wang, Hao Yan ^a   Casaburi, Richard ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Chronic obstructive pulmonary disease; Exercise; Spirometry

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; EXERCISE; EXERCISE TEST; EXERCISE TOLERANCE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; SLOW VITAL CAPACITY; SPIROMETRY;

EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TIME FACTORS; VITAL CAPACITY;

EID: 84896710679     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-14-16     Document Type: Article

References (18)

1. Global Initiative for Chronic Obstructive Lung Disease Global strategy for diagnosis, management and prevention of COPD. (updated 2011). http://www.goldcopd.com, Global Initiative for Chronic Obstructive Lung Disease.
2. Oga T, Nishimura K, Tsukino M, et al. Exercise capacity deterioration in patients with COPD: Longitudinal evaluation over 5 years. Chest 2005, 128:62-69. 10.1378/chest.128.1.62, 16002917.
3. O'Donnell DE, Lam M, Webb KA. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999, 160:542-549. 10.1164/ajrccm.160.2.9901038, 10430726.
4. O'Donnell DE, Voduc N, Fitzpatrick M, Webb KA. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. Eur Respir J 2004, 24:86-94. 10.1183/09031936.04.00072703, 15293609.
5. O'Donnell DE, Sciurba F, Celli B, Mahler DA, Webb KA, Kalberg CJ, Knobil K. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. Chest 2006, 130:647-656. 10.1378/chest.130.3.647, 16963658.
6. Garcia-Rio F, Lores V, Mediano O, et al. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 2009, 180:506-512. 10.1164/rccm.200812-1873OC, 19542481.
7. O'Donnell DE, Revill SM, Webb KA. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001, 164:770-777. 10.1164/ajrccm.164.5.2012122, 11549531.
8. Ferguson GT. Why does the lung hyperinflate?. Proc Am Thorac Soc 2006, 3:176-179. 10.1513/pats.200508-094DO, 16565428.
9. Lammi MR, Ciccolella D, Marchetti N, Kohler M, Criner G. Increased oxygen pulse after lung volume reduction surgery is associated with reduced dynamic hyperinflation. Eur Respir J 2012, 40:837-843. 10.1183/09031936.00169311, 22267766.
10. O'Donnell DE, Guenette JA, Maltais F, Webb KA. Decline of resting inspiratory capacity in COPD. Chest 2012, 141:753-762. 10.1378/chest.11-0787, 21852298.
11. Chhabra SK. Forced vital capacity, slow vital capacity, or inspiratory vital capacity: which is the best measure of vital capacity. J Asthma 1998, 35:361-365. 10.3109/02770909809075669, 9669830.
12. Brusasco V, Pellegrino A, Rodarte JR. Vital capacities in acute and chronic airway obstruction: dependence on flow and volume histories. Eur Respir J 1997, 10:1316-1320. 10.1183/09031936.97.10061316, 9192935.
13. O'Brien C, Guest PJ, Hill SL, et al. Physiological and radiological characterization of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax 2000, 55:635-642. 10.1136/thorax.55.8.635, 1745831, 10899238.
14. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005, 26:319-338. 10.1183/09031936.05.00034805, 16055882.
15. American Thoracic Society/American College of Chest Physicians ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003, 167:211-277. American Thoracic Society/American College of Chest Physicians.
16. Cohen J, Postma DS, Vin-Klooster K, et al. FVC to slow inspiratory vital capacity ratio, a potential marker for small airways obstruction. Chest 2007, 132:1198-1203. 10.1378/chest.06-2763, 17890480.
17. Chan ED, Irvin CG. The detection of collapsible airways contributing to airflow limitation. Chest 1995, 107:856-859. 10.1378/chest.107.3.856, 7874964.
18. Levitzky MG. Pulmonary physiology 1982, 1-12. New York: McGraw-Hill.